New cancer clinical trial: A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA
Published on: September 20, 2018 at 12:00PM Condition: Colorectal Cancer With Liver Metastases Intervention: Sponsor: Fudan University Recruiting
https://ift.tt/2QO2rVR
No comments:
Post a Comment